152 related articles for article (PubMed ID: 8100210)
1. Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.
Shipman R; Schraml P; Colombi M; Raefle G; Ludwig CU
Hum Genet; 1993 Jun; 91(5):455-8. PubMed ID: 8100210
[TBL] [Abstract][Full Text] [Related]
2. Deletion mapping of chromosome 11 in carcinoma of the bladder.
Shaw ME; Knowles MA
Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
[TBL] [Abstract][Full Text] [Related]
3. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Genes Chromosomes Cancer; 1994 Jul; 10(3):183-9. PubMed ID: 7522041
[TBL] [Abstract][Full Text] [Related]
4. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns P; Shaw ME; Knowles MA
Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.
Brewster SF; Gingell JC; Browne S; Brown KW
Br J Cancer; 1994 Oct; 70(4):697-700. PubMed ID: 7917921
[TBL] [Abstract][Full Text] [Related]
6. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
7. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
8. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
[TBL] [Abstract][Full Text] [Related]
9. Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
Shipman R; Schraml P; Colombi M; Ludwig CU
Int J Oncol; 1998 Jan; 12(1):107-11. PubMed ID: 9454893
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
11. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
12. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.
Viel A; Giannini F; Tumiotto L; Sopracordevole F; Visentin MC; Boiocchi M
Br J Cancer; 1992 Dec; 66(6):1030-6. PubMed ID: 1360809
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
Takle LA; Knowles MA
Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
16. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
Tran YK; Newsham IF
Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
Bell SM; Zuo J; Myers RM; Knowles MA
Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
[TBL] [Abstract][Full Text] [Related]
18. Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer.
Ludwig CU; Raefle G; Dalquen P; Stulz P; Stahel R; Obrecht JP
Int J Cancer; 1991 Nov; 49(5):661-5. PubMed ID: 1682278
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss on chromosome 11p is a less frequent event in bilateral than in unilateral Wilms' tumours.
Little MH; Clarke J; Byrne J; Dunn R; Smith PJ
Eur J Cancer; 1992; 28A(11):1876-80. PubMed ID: 1356388
[TBL] [Abstract][Full Text] [Related]
20. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
